- Market Realist•5 hours ago
Incyte’s (INCY) Jakafi is distributed in the United States through a network of specialty pharmacy providers and wholesalers for direct delivery.
- Market Realist•6 hours ago
Incyte has classified its oncology product portfolio into targeted anti-cancer therapies and immuno-oncology or immunotherapies.
- Market Realist•8 hours ago
Revenues for Jakafi rose more than 42.0% to $852.8 million in 2016, from $601.0 million in 2015.
INCY : Summary for Incyte Corporation - Yahoo Finance
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||133.04 x 200|
|Ask||133.10 x 200|
|Day's Range||131.91 - 135.48|
|52 Week Range||60.30 - 135.48|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||246.37|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|